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Abstract 
The peptide hormone gastrin17, which occurs naturally in both tyrosine sulphated and unsulphated forms, binds two 
ferric ions with pM affinities. The aim of this study was to investigate the hypothesis that sulphation or phosphoryla-
tion of gastrin17 altered ferric ion binding, and/or affinity for the CCK1 or CCK2 receptor. To investigate the effect of 
tyrosine modification on ferric ion binding, the changes in absorbance of gastrin17, gastrin17SO4 and gastrin17PO4 on 
addition of Fe3+ ions were monitored. Binding of gastrin17, gastrin17SO4 and gastrin17PO4 to the human CCK1 and 
CCK2 receptors was assessed by competition with [125I]-Bolton and Hunter-labelled cholecystokinin8 in transiently 
transfected COS cells. Tyrosine sulphation or phosphorylation increased the affinity of gastrin17 for the first ferric ion 
bound from 267 to 83 pM and 14 pM, respectively, but had no effect on the stoichiometry of ferric ion binding. In 
contrast the affinity of gastrin17 for the second ferric ion bound was reduced from 94 pM to 7.32 µM and 671 nM, 
respectively. While sulphation of gastrin17 increased its affinity for the CCK2 receptor approximately 50 fold, phospho-
rylation had no effect on receptor binding. These results demonstrate that tyrosine modification may have profound 
effects on the interaction of gastrins with ferric ions and with the CCK2 receptor.
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Background
The classical gastrointestinal hormone gastrin17 (ZGP-
WLEEEEEAYGWMDFamide, Gamide) was first rec-
ognized by its ability to stimulate gastric acid secretion 
(Dockray et  al. 2001). Human gastrin is initially synthe-
sized as a 101 amino acid preprohormone, which is pro-
cessed via the 80 amino acid prohormone progastrin, 
to various non-amidated precursors including glycine-
extended gastrin17 (ZGPWLEEEEEAYGWMDFG, Ggly) 
(Dockray et  al. 2001). While Gamide stimulates prolif-
eration in the gastric mucosa (Koh et al. 1999), progastrin 
and Ggly are important growth factors for the colorectal 
mucosa (Aly et al. 2004). The related hormone cholecys-
tokinin (CCK), which has the same amidated C-terminal 
pentapeptide sequence as gastrin17, is responsible for 
gallbladder contraction and pancreatic enzyme secretion 
(Miyasaka and Funakoshi 2003).
The receptors for CCK (CCK1 receptor) and Gamide 
(CCK2 receptor) are both members of the seven trans-
membrane domain family, and share 50  % sequence 
identity (Aly et al. 2004; Shulkes and Baldwin 1997). The 
CCK1 receptor is found on pancreatic acini and has a 
1000-fold higher affinity for sulphated CCK8 (CCK8SO4) 
than for unsulphated CCK8. However, sulphation of 
CCK8 does not greatly affect its affinity for the CCK2 
receptor, which is found in the gastric mucosa and in the 
brain (Shulkes and Baldwin 1997). Neither the CCK1 nor 
the CCK2 receptor recognizes non-amidated forms of 
CCK or gastrin, but the receptors can be readily distin-
guished with several selective antagonists (Shulkes and 
Baldwin 1997).
Gastrins such as Ggly and Gamide bind two ferric 
ions (Baldwin et al. 2001), the first to Glu7 and the sec-
ond to Glu8 and Glu9 (Baldwin et  al. 2015; Pannequin 
et  al. 2002). Ferric ions are essential for the biological 
activity of Ggly as a stimulant of cell proliferation and 
migration (Pannequin et  al. 2002), but are not required 
for the biological activity of Gamide (Pannequin et  al. 
2004). For example, treatment with the iron chelator 
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desferrioxamine, or substitution of Glu7 with Ala, com-
pletely blocked the biological activity of Ggly (Pannequin 
et al. 2002), but had no effect on the biological activity of 
Gamide (Pannequin et al. 2004).
Sulphation of CCK8 on the sole tyrosine residue greatly 
increases receptor binding and biological potency (Jensen 
et  al. 1981). Tyrosine sulphation or phosphorylation of 
CCK8 increased the stoichiometry of ferric ion binding 
from 1 to 2, without greatly affecting the affinity (Baldwin 
et  al. 2008). Gastrins also occur in sulphated and unsul-
phated forms (Dockray et  al. 2001), and the sulphated 
form predominates in the fetal pancreas (Brand et  al. 
1984). Gastrin can also be phosphorylated by the EGF 
receptor tyrosine kinase in vitro (Baldwin et al. 1983), but 
phosphorylated gastrins have not been reported to occur 
naturally. The aim of the present study was to determine 
whether or not sulphation or phosphorylation of gas-
trin17 altered ferric ion binding or affinity for the CCK1 
or CCK2 receptor. Since non-amidated forms of gastrin 
require ferric ions for activity, a change in affinity for fer-
ric ions on modification of the tyrosine residue of gastrins 
might have profound effects on their biological activity.
Methods
Peptides
Gastrin17 and sulphated gastrin17 (95 and 96  % pure, 
respectively) were purchased from Bachem (Bubendorf, 
Switzerland). Phosphorylated gastrin17 (85  % pure) was 
from Mimotopes (Clayton, Australia). All peptides had 
a pyroglutamyl residue at their N-terminus and were 
C-terminally amidated. The impurities consisted of water 
and salts.
Absorption spectroscopy
The absorption of peptides (10  μM in 10  mM sodium 
acetate (pH 4.0) containing 100  mM NaCl and 0.005  % 
Tween 20) at 280 nm in the presence of increasing con-
centrations of ferric ions from 2.5 to 50  μM was meas-
ured against a buffer blank, in 1  ml quartz cuvettes 
thermostatted at 298 K, with a Cary 5 spectrophotometer 
(Varian, Mulgrave, Australia).
Receptor binding assay
Binding of ligands to the human CCK1 or CCK2 recep-
tors on transiently transfected COS-7 cells was measured 
by competition with sulfated [125I]-Bolton and Hunter 
labelled-CCK8 (50,000 cpm/well, Amersham Biosciences, 
Castle Hill, Australia) as described previously (Baldwin 
et al. 2008).
Curve fitting and statistics
Data [expressed as mean ± standard error of the means 
(SEM)] for the binding of ferric ions to gastrins were 
fitted to a two-site ordered model with the program 
BioEqs (Royer 1993; Royer et  al. 1990). Receptor bind-
ing data were analyzed by one-way analysis of variance, 
followed by Bonferroni’s t test. Differences with P values 
<0.05 were considered significant.
Results and discussion
Changes in absorbance on binding of ferric ions 
to tyrosine‑modified gastrin17
The effect of addition of Fe3+ ions on the absorption 
spectrum of gastrin17, gastrin17SO4 and gastrin17PO4 
was first investigated by absorption spectroscopy. A pH 
value of 4.0 was chosen in order to avoid any problems 
with precipitation of ferric hydroxides, and to allow 
direct comparison with previous studies. As reported 
previously (Baldwin et  al. 2001, 2015) the absorption of 
gastrin17 at 280  nm increased to a maximum of 220  % 
after the addition of 2.0  mol ferric chloride/mol pep-
tide (Fig. 1a). Fitting of the absorption data to a two-site 
ordered model with the program BioEqs gave values for 
Kd1 and Kd2 of 267 and 94  pM, respectively, in good 
agreement with the values determined previously (Bald-
win et  al. 2015) (Table  1). The increase in absorption 
of gastrin17SO4 (Fig.  1b) on addition of ferric ions was 
more gradual than for gastrin17, and in the case of gas-
trin17PO4 a slight decrease in absorption was initially 
observed (Fig. 1c). Nevertheless the absorption for both 
gastrin17SO4 and gastrin17PO4 finally reached maxima of 
195 % to 220 % after the addition of 2–3 mol ferric chlo-
ride/mol peptide. Fitting of the absorption data to a two-
site ordered model with the program BioEqs gave values 
for Kd1 and Kd2 of 83 pM and 7.32 µM, respectively, for 
gastrin17SO4, and of 14 pM and 671 nM, respectively, for 
gastrin17PO4 (Table 1).
This data indicates that, although tyrosine sulphation 
or phosphorylation had no effect on the stoichiometry of 
ferric ion binding, the affinity of gastrin for the first fer-
ric ion was enhanced, and for the second ferric ion was 
reduced, by modification of the tyrosine side chain. The 
possibility that the hydroxyl group of the tyrosine is itself 
a ligand for the second ferric ion does not appear to be 
likely as XAFS data suggested that three of the five glu-
tamate side chains act as ferric ion ligands (Baldwin et al. 
2015). A more likely explanation is that the bulky sul-
phate and phosphate groups occupy the ferric ion bind-
ing site and prevent access of more than one ferric ion.
The concentrations of gastrins and of ferric ions used 
in the above experiments were supra-physiological. The 
concentration of gastrins was chosen as the minimum 
concentration that gave a reproducible change in absorb-
ance on addition of ferric ions. Nevertheless our previ-
ous publications indicate that the binding of ferric ions 
to gastrin at physiological concentrations is essential for 
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biological function. Thus mutation of the glutamate resi-
dues essential for binding ferric ions abrogates the bio-
logical activity of Ggly as a stimulant of cell proliferation 
and migration (Pannequin et al. 2002). Similarly removal 
of ferric ions with the iron chelator desferrioxamine 
(Ferrand et al. 2010; Pannequin et al. 2002), or by com-
petition with bismuth ions (Kovac et al. 2012; Pannequin 
et al. 2002), blocked the biological activity of Ggly in vitro 
and in vivo.
Effect of tyrosine modification on CCK receptor binding
The effect of tyrosine modification on the binding of gas-
trin17 to either human CCK1 or CCK2 receptors was then 
examined. Although sulphation of gastrin17 increased 
its affinity for the human CCK2 receptor, phosphoryla-
tion of gastrin17 had no effect on CCK2 receptor binding 
(Fig. 2b). The IC50 values for the binding of gastrin17, gas-
trin17SO4 and gastrin17PO4 to the CCK2 receptor were 
61 ± 32, 1.2 ± 0.4 and 58 ± 20 nM, respectively. The IC50 
values for the binding of gastrin17 were slightly higher 
than the values, which range from 0.94 to 6.4 nM, previ-
ously reported for the cloned human CCK2 receptor (Ito 
et al. 1993; Lee et al. 1993; Pisegna et al. 1992). The affin-
ity of gastrin17SO4 for the cloned human CCK2 recep-
tor does not appear to have been reported previously, 
but data for binding to dispersed gastric glands from the 
guinea pig fundus also suggest that sulphation increases 
the affinity for the CCK2 receptor, in that case by a fac-
tor of tenfold, from 16 to 1.6 nM (Praissman et al. 1983). 
Binding of gastrin17, gastrin17SO4 and gastrin17PO4 to 
the CCK1 receptor was not detected in our experiments 
(Fig.  2a). In the case of gastrin17 this result agrees with 




Fig. 1 Tyrosine sulphation of gastrin enhances ferric ion binding. As 
reported previously, addition of aliquots of ferric chloride to 10 µM 
gastrin17 (a, down triangle) in 10 mM sodium acetate, 100 mM NaCl, 
0.005 % Tween 20, pH 4.0 at 298 K resulted in an increase in the 
absorption at 280 nm up to a molar ratio of 2. Addition of aliquots of 
FeCl3 to 10 µM gastrin17SO4 (b, diamond), or gastrin17PO4 (c, up trian-
gle) caused a more gradual change in absorption. Data are expressed 
as a percentage of the absorbance of that peptide without ferric ions. 
Points are means of at least three separate experiments; bars repre-
sent the SEM. Lines represent the best fit to a two site model with the 
program BioEqs; the appropriate Kd values are given in Table 1
Table 1 Binding of ferric ions by gastrin17, CCK8 and their 
derivatives
The affinity of, and the percentage absorbance change at 280 nm on, the 
binding of the first and second ferric ions to gastrin17, gastrin17SO4 or 
gastrin17PO4 at pH 4.0 were determined by fitting the mean data obtained in 
the absorbance experiments (N = 3) described in the Fig. 1 legend to a two site 
ordered model with the program BioEqs
a The absorbance changes for CCK8 and its derivatives were measured at 275 nM 
as the peptide contains tyrosine and phenylalanine, but no tryptophan, residues 
(Baldwin et al. 2008)
Reference Absorption






Gastrin17 267 94 100 223
Gastrin17 Baldwin et al. 
(2015)
300 85 100 313
Gastrin17SO4 83 7,320,000 88 259
Gastrin17PO4 14 671,000 98 215
CCK8 Baldwin et al. 
(2008)
Not detected
CCK8SO4 Baldwin et al. 
(2008)
Not detected
CCK8PO4 Baldwin et al. 
(2008)
Cooperative Cooperative 194a
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an IC50 value of 1.8 µM (de Weerth et al. 1993); binding 
affinities of gastrin17SO4 and gastrin17PO4 for the CCK1 
receptor do not appear to have been reported previously.
Comparison with CCK8
In contrast to CCK8, where tyrosine sulphation or phos-
phorylation increased the stoichiometry of ferric ion 
binding from 1 to 2 without greatly affecting the affinity 
(Baldwin et al. 2008), tyrosine sulphation or phosphoryl-
ation of gastrin17 had no effect on the stoichiometry of 
ferric ion binding, but enhanced the affinity of gastrin17 
for the first ferric ion, and reduced the affinity for the 
second ferric ion. This difference is not unexpected as the 
gastrin binding site consists of three of the five glutamate 
residues, while the CCK8SO4 binding site involves the 
two aspartate residues, and the CCK8PO4 binding site the 
phosphate group itself (Baldwin et al. 2008). In terms of 
receptor binding, tyrosine sulphation enhanced the affin-
ity, while phosphorylation reduced the affinity, of CCK8 
for both the CCK1 and CCK2 receptors (Baldwin et  al. 
2008). In contrast, while tyrosine sulphation enhanced 
the affinity of gastrin17 for the CCK2 receptor, phospho-
rylation had no effect. Although the generalization that 
modification of tyrosine profoundly affects the binding 
of ferric ions is valid, the differences between two such 
closely related peptides as gastrin17 and CCK8 indicate 
that the exact binding details will have to be determined 
for each peptide individually.
Conclusions
While tyrosine sulphation or phosphorylation of gastrin17 
had no effect on the stoichiometry of Fe3+ ion binding, 
the affinity for the first ferric ion bound was increased 
from 267 to 83 pM and 14 pM, respectively. Sulphation 
of gastrin17 increased its affinity for the CCK2 receptor 
approximately 50 fold, but phosphorylation had no effect 
on receptor binding. These results imply that tyrosine 
modification may have profound effects on the biological 
activities of gastrins.
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